Graeme Martin Brown
Corporate Officer/Principal bei University of London
Profil
Graeme Martin Brown is the founder of Vaxome Ltd.
and Activiomics Ltd.
He currently works as the Director of Technology Transfer at the University of London.
He holds a doctorate degree from the University of Cambridge.
Aktive Positionen von Graeme Martin Brown
Unternehmen | Position | Beginn |
---|---|---|
University of London | Corporate Officer/Principal | 01.01.2002 |
Ehemalige bekannte Positionen von Graeme Martin Brown
Unternehmen | Position | Ende |
---|---|---|
Activiomics Ltd.
Activiomics Ltd. Miscellaneous Commercial ServicesCommercial Services Activiomics Ltd. develops innovative technologies that utilize mass spectrometry to interrogate and interpret the activity of cellular signaling pathways. It offers phosphoproteomics for biomaker discovery and drug profiling. The company was founded by Bart Vanhaesebroeck and Pedro Rodriguez Cutillas in 2009 and is headquartered in London, the United Kingdom. | Gründer | 16.03.2011 |
Vaxome Ltd.
Vaxome Ltd. Pharmaceuticals: MajorHealth Technology Vaxome Ltd. developed vaccine delivery technology. The firm offered a novel vaccine delivery technology for antigen presentation and delivery system for stimulating T cell-mediated immune responses. The company was founded by Ping Wang in 2004 and was headquartered in London, the United Kingdom. | Gründer | - |
Ausbildung von Graeme Martin Brown
University of Cambridge | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Vaxome Ltd.
Vaxome Ltd. Pharmaceuticals: MajorHealth Technology Vaxome Ltd. developed vaccine delivery technology. The firm offered a novel vaccine delivery technology for antigen presentation and delivery system for stimulating T cell-mediated immune responses. The company was founded by Ping Wang in 2004 and was headquartered in London, the United Kingdom. | Health Technology |
Activiomics Ltd.
Activiomics Ltd. Miscellaneous Commercial ServicesCommercial Services Activiomics Ltd. develops innovative technologies that utilize mass spectrometry to interrogate and interpret the activity of cellular signaling pathways. It offers phosphoproteomics for biomaker discovery and drug profiling. The company was founded by Bart Vanhaesebroeck and Pedro Rodriguez Cutillas in 2009 and is headquartered in London, the United Kingdom. | Commercial Services |